JND Banner MadMimi
 

Please feel free forward to your colleagues and share the news of our journal

***
JND-in-the-news-banner

We are pleased to announce that JND has received notification that, since June 2021, it is listed in the Science Citation Index-Expanded category in the Web of Science, the citation database that generates impact factors. This will provide greater discoverability for JND articles leading to measurable citations and it is expected that the journal will be assigned its first impact factor in 2022.

JND MadMimi lijn2

NEW ISSUE

Volume 8, Issue 4 Now Online

REVIEW ARTICLES
Early Gross Motor Milestones in Duchenne Muscular DystrophyOpen Access
Norcia, Giulia | Lucibello, Simona | Coratti, Giorgia | Onesimo, Roberta | Pede, Elisa | Ferrantini, Gloria | Brogna, Claudia | Cicala, Graziamaria | Carnicella, Sara | Forcina, Nicola | et al.

The Role of Nutrition and Physical Activity as Trigger Factors of Paralytic Attacks in Primary Periodic ParalysisOpen Access
Welland, Natasha Lervaag | Hæstad, Helge | Fossmo, Hanne Ludt | Giltvedt, Kaja | Ørstavik, Kristin | Nordstrøm, Marianne

RESEARCH ARTICLES
Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History ControlsOpen Access
Mendell, Jerry R. | Khan, Navid | Sha, Nanshi | Eliopoulos, Helen | McDonald, Craig M. | Goemans, Nathalie | Mercuri, Eugenio | Lowes, Linda P. | et al.

Vitamin D Level Stability in Dystrophinopathy Patients on Vitamin D Supplementation
Vather-Wu, Naomi | Krasowski, Matthew D. | Mathews, K.D. | Shibli-Rahhal, Amal

Evaluation of the Lipid-binding Properties of Recombinant Dystrophin Spectrin-like Repeat Domains R1-3Open Access
Cooper-Olson, Grace | Rodino-Klapac, Louise R. | Potter, Rachael A.

Improved Cardiac Outcomes by Early Treatment with Angiotensin-Converting Enzyme Inhibitors in Becker Muscular DystrophyOpen Access
Stalens, Caroline | Motté, Leslie | Béhin, Anthony | Ben Yaou, Rabah | Leturcq, France | Bassez, Guillaume | Laforêt, Pascal | Fontaine, Bertrand | Ederhy, Stéphane | et al.

Clinical Management of Duchenne Muscular Dystrophy in the Netherlands: Barriers to and Proposals for the Implementation of the International Clinical Practice Guidelines
Heutinck, Lotte | van Gameren, Maaike | Verschuuren, Jan J.G.M. | Geurts, Alexander C.H. | Jansen, Merel | de Groot, Imelda J.M.

Histological Analysis of Tibialis Anterior Muscle of DMD mdx4Cv Mice from 1 to 24 Months
Ben Larbi, Sabrina | Saclier, Marielle | Fessard, Aurélie | Juban, Gaëtan | Chazaud, Bénédicte

Comparison of The Carrier Frequency of Pathogenic Variants of DMD Gene in an Indian Cohort
Nagabushana, Divya | Polavarapu, Kiran | Bardhan, Mainak | Arunachal, Gautham | Gunasekaran, Swetha | Preethish-Kumar, Veeramani | Anjanappa, Ram Murthy | et al.

Effect of Discontinuation of Nusinersen Treatment in Long-Standing SMA3
Hiebeler, Miriam | Abicht, Angela | Reilich, Peter | Walter, Maggie C.

Improving Care and Empowering Adults Living with SMA: A Call to Action in the New Treatment EraOpen Access
Walter, Maggie C. | Chiriboga, Claudia | Duong, Tina | Goemans, Nathalie | Mayhew, Anna | Ouillade, Laëtitia | Oskoui, M. | Quinlivan, Ros | Vázquez-Costa, J.F. | et al.

Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in CanadaOpen Access
McMillan, H.J. | Gerber, B. | Cowling, T. | Khuu, W. | Mayer, M. | Wu, J.W. | Maturi, B. | Klein-Panneton, K. | Cabalteja, C. | Lochmüller, H.

Characterization of Adult Patients With SMA Treated in US Hospital Settings: A Natural History Study in the Premier Healthcare DatabaseOpen Access
Johnson, Nicole B. | Proud, Crystal | Wassel, Christina L. | Dreyfus, Jill | Cochrane, Thos | Paradis, Angela D.

A Canadian Adult Spinal Muscular Atrophy Outcome Measures Toolkit: Results of a National Consensus using a Modified Delphi MethodOpen Access
Slayter, Jeremy | Hodgkinson, Victoria | Lounsberry, Josh | Brais, Bernard | Chapman, Kristine | Genge, Angela | Izenberg, Aaron | Johnston, Wendy | Lochmüller, Hanns | et al.

Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New ModuleOpen Access
Berti, Beatrice | Fanelli, Lavinia | de Sanctis, Roberto | Onesimo, Roberta | Palermo, Concetta | Leone, Daniela | Carnicella, Sara | Norcia, Giulia | Forcina, Nicola | et al.

MEETING REPORTS
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 1st eNMD Congress: Nice, France, March 22-23, 2019Open Access
Pini, Jonathan | Siciliano, Gabriele | Lahaut, Pauline | Braun, Serge | Segovia-Kueny, Sandrine | Kole, Anna | Hérnando, Ines | Selb, Julij | Schirinzi, Erika | et al.

Abstracts from the International Congress on Neuromuscular Diseases, September 11-14, 2020: A Virtual EventOpen Access
Vilchez Padilla, Juan Jesús

JND MadMimi lijn2

ABSTRACTS ISSUE

Volume 8, Supplement 1 / 2021 Freely Available Online

The 2021 International Congress on Neuromuscular Disease (ICNMD) meeting was a great success. The event, held online in early May 2021, provided an opportunity to obtain new perspectives on neuromuscular diseases. The abstracts of the meeting have been published as a supplement to JND (JND 8:s1), which is freely available to read, download and share. The content covers a wide spectrum of neuromuscular diseases from the perspectives of advances in research, diagnosis, and treatment, including: muscle disorders; peripheral neuropathies; neuromuscular junction disorders; and motor neuron diseases. View the abstracts.

JND MadMimi lijn2

ICYMI: Open Access Special Issue

Treatabolome, an Emerging Concept

(Guest Editor: Gisèle Bonne, PhD)

JND MadMimi lijn2

TREAT-NMD News

2022 Conference: Save the Date!

TREAT-NMD is organising the 7th international conference focusing on translational medicine in inherited neuromuscular diseases to be held from June 15–17, 2022 in Vancouver in Canada. The aim of this international conference will be to share progress and lessons learned in the area of translational medicine in inherited neuromuscular diseases and plan for the delivery of future therapies to patients.

More details will be available via the conference website in due course.

JND MadMimi lijn2

Most Read JND Articles in July 2021

Listing articles published only in 2020 and 2021 so you can read the most popular recent content

Current View of Diagnosing Small Fiber NeuropathyOpen Access (Review Article in Vol.8, Iss.2, 2021)
Raasing, Lisette R.M. | Vogels, Oscar J.M. | Veltkamp, Marcel | van Swol, Christiaan F.P. | Grutters, Jan C.

Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI TrialOpen Access (Research Article in pre-press, 2021)
McDonald, Craig M. | Shieh, Perry B. | Abdel-Hamid, Hoda Z. | Connolly, Anne M. | Ciafaloni, Emma | Wagner, Kathryn R. | Goemans, Nathalie | Mercuri, Eugenio | et al.

Advances in Treatment of Spinal Muscular Atrophy – New Phenotypes, New Challenges, New Implications for CareOpen Access (Review Article in Vol.7, Iss.1, 2020)
Schorling, David C. | Pechmann, Astrid | Kirschner, Janbernd

Molecular Mechanisms of Skeletal Muscle HypertrophyOpen Access (Review Article in Vol.8, Iss.2, 2021)
Schiaffino, Stefano | Reggiani, Carlo | Akimoto, Takayuki | Blaauw, Bert

Exon-Skipping in Duchenne Muscular DystrophyOpen Access (Review Article in pre-press, 2021)
Takeda, Shin’ichi | Clemens, Paula R. | Hoffman, Eric P.

JND MadMimi lijn2

Sign Ups & Social Media

Help Spread the News of JND!

If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the sign-up link at the bottom of this email or access here.

If you are not yet interacting with JND on social media, why not take the time today to follow us on Twitter and find us on Facebook?

Be part of the discussion!

JND MadMimi lijn2
JND cover klein

Indexed in: PubMed/MEDLINE Scopus

Submit your Paper

As a member of our research community, we would like to invite you to contribute your own articles to the journal. JND offers contributing authors many benefits, including rigorous peer review and speedy manuscript processing, rapid online publication (pre-press) and an affordable open access option (€1250/US$1450). JND is fully compliant with all mandates by major funders, and open access articles are automatically uploaded to PubMed Central. More reasons to publish in JND are outlined on the journal's website!

Submit your manuscript online via MsTracker
View detailed Instructions to Authors
Aims and Scope

JND MadMimi lijn2
***

You are receiving this mailing as you are signed up to receive news from JND.
You can unsubscibe or alter your preferences at any time by clicking the links below
.

 
 
Powered by Mad Mimi®A GoDaddy® company